Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ANIX

Anixa Biosciences, Inc.

Healthcare · USD

Set alert

Price alert · ANIX

All alert types
3.12 USD -0.18 -5.45%
As of Oct 30, 2026 Extended hours 3.12 +0.04%
Bid
3.12 × 2
Ask
3.14 × 2
3.10 Day range 3.35
2.35 52-week range 5.22
YTD
0.00%
1 year
-23.15%
Open
3.28
Prev close
3.30
Mkt cap
108.46M
Vol
140.66K
Avg vol
279.08K
EPS
-0.32
P/E
0.00
Div yield
0.00%
More statistics
Low
3.10
High
3.35
Forward P/E
-7.17
Beta
0.85
Short ratio
3.03
Inst. own
17.46%
Dividend
0.00
Ex-div date
Earnings
Jan 21, 2025
50-d avg
3.17
200-d avg
3.04
1y target
8.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ANIX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

9.39 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -12.1×
FY 2016: -11.1×FY 2017: -5.0×FY 2018: -5.1×FY 2019: -6.3×FY 2020: -4.5×FY 2021: -11.3×FY 2022: -12.4×FY 2023: -9.9×FY 2024: -9.0×FY 2025: -12.1×
FY 2016 5y median -11.3× FY 2025
P/S 0.0×
FY 2016: 185×FY 2017: 69.0×FY 2018: 64.2×FY 2019: 306×FY 2020: 0.0×FY 2021: 284×FY 2022: 0.0×FY 2023: 466×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 8.8×
FY 2016: 56.2×FY 2017: 3.2×FY 2018: 13.1×FY 2019: 14.6×FY 2020: 5.2×FY 2021: 4.1×FY 2022: 5.9×FY 2023: 4.0×FY 2024: 5.6×FY 2025: 8.8×
FY 2016 5y median 5.6× FY 2025
P/FCF -18.7×
FY 2016: -15.7×FY 2017: -6.5×FY 2018: -16.6×FY 2019: -15.6×FY 2020: -7.4×FY 2021: -29.5×FY 2022: -26.2×FY 2023: -15.8×FY 2024: -15.2×FY 2025: -18.7×
FY 2016 5y median -18.7× FY 2025
EV/EBITDA -12.1×
FY 2016: -13.8×FY 2017: -5.2×FY 2018: -4.9×FY 2019: -6.6×FY 2020: -3.9×FY 2021: -8.9×FY 2022: -11.5×FY 2023: -9.8×FY 2024: -8.7×FY 2025: -12.1×
FY 2016 5y median -9.8× FY 2025
EV/Sales 0.0×
FY 2016: 191×FY 2017: 59.8×FY 2018: 61.4×FY 2019: 292×FY 2020: 0.0×FY 2021: 228×FY 2022: 0.0×FY 2023: 463×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -5.4%
FY 2016: -6.4%FY 2017: -15.3%FY 2018: -6.0%FY 2019: -6.4%FY 2020: -13.5%FY 2021: -3.4%FY 2022: -3.8%FY 2023: -6.3%FY 2024: -6.6%FY 2025: -5.4%
FY 2016 5y median -5.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 27.5%FY 2017: 71.2%FY 2018: 1.7%FY 2019: 33.5%FY 2020: 0.0%FY 2021: 24.8%FY 2022: 0.0%FY 2023: 23.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -1503.0%FY 2017: -1676.0%FY 2018: -1232.0%FY 2019: -4756.0%FY 2020: 0.0%FY 2021: -2565.6%FY 2022: 0.0%FY 2023: -5243.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -1672.1%FY 2017: -1381.8%FY 2018: -1258.1%FY 2019: -4658.8%FY 2020: 0.0%FY 2021: -2528.6%FY 2022: 0.0%FY 2023: -4671.9%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -72.1%
FY 2016: -508.0%FY 2017: -63.2%FY 2018: -257.5%FY 2019: -222.5%FY 2020: -115.7%FY 2021: -36.5%FY 2022: -46.8%FY 2023: -40.3%FY 2024: -62.8%FY 2025: -72.1%
FY 2016 5y median -46.8% FY 2025
ROIC -82.7%
FY 2016: -87.4%FY 2017: -76.7%FY 2018: -264.4%FY 2019: -247.1%FY 2020: -119.9%FY 2021: -37.5%FY 2022: -48.8%FY 2023: -46.8%FY 2024: -72.3%FY 2025: -82.7%
FY 2016 5y median -48.8% FY 2025
ROA -68.0%
FY 2016: -89.1%FY 2017: -56.8%FY 2018: -217.0%FY 2019: -185.1%FY 2020: -107.2%FY 2021: -35.7%FY 2022: -44.7%FY 2023: -38.4%FY 2024: -58.1%FY 2025: -68.0%
FY 2016 5y median -44.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -96.8%FY 2017: 20.8%FY 2018: 206.9%FY 2019: -77.5%FY 2020: -100.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 15.4%
FY 2016: -377.3%FY 2017: -34.7%FY 2018: -125.6%FY 2019: 13.3%FY 2020: 16.1%FY 2021: -31.6%FY 2022: -5.6%FY 2023: 20.6%FY 2024: -25.6%FY 2025: 15.4%
FY 2016 FY 2025
EPS (diluted) 12.8%
FY 2016: -307.1%FY 2017: 28.1%FY 2018: -92.7%FY 2019: 22.8%FY 2020: 24.6%FY 2021: 2.2%FY 2022: 0.0%FY 2023: 28.9%FY 2024: -21.9%FY 2025: 12.8%
FY 2016 FY 2025
Free Cash Flow 2.2%
FY 2016: -369.6%FY 2017: -8.5%FY 2018: -12.7%FY 2019: -14.0%FY 2020: -25.9%FY 2021: 20.2%FY 2022: -31.5%FY 2023: 4.4%FY 2024: -18.1%FY 2025: 2.2%
FY 2016 FY 2025

Financial Health

Current Ratio 8.1×
FY 2016: 7.3×FY 2017: 7.9×FY 2018: 4.4×FY 2019: 4.1×FY 2020: 7.9×FY 2021: 28.3×FY 2022: 14.8×FY 2023: 12.5×FY 2024: 8.5×FY 2025: 8.1×
FY 2016 5y median 12.5× FY 2025
Quick Ratio 8.1×
FY 2016: 7.3×FY 2017: 7.9×FY 2018: 4.4×FY 2019: 5.7×FY 2020: 7.9×FY 2021: 28.3×FY 2022: 14.8×FY 2023: 12.5×FY 2024: 8.5×FY 2025: 8.1×
FY 2016 5y median 12.5× FY 2025
Debt / Equity 0.0×
FY 2016: 4.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: -0.4×FY 2017: 0.8×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.6×FY 2021: 2.2×FY 2022: 0.9×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: -8.7×FY 2017: -12.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -40794×FY 2022: -133×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-10-31